Myeloma Minute
June 28, 2012
|
|
|
06.28.12 |
 |
 |
 |
 |
|
June 28, 2012
|
 |
 |
 |
 |
 |
 |
| |
 |
|
Reserve Your Tickets Now!
Tickets are now on sale for the IMF’s 6th Annual Comedy Celebration being held on October 27 in Los Angeles. Make plans to join us for the laughs and fun! LEARN MORE
No-Sweat Summer Fundraisers That Can Make a Difference
Get involved, have fun and make a difference this summer by helping fund myeloma research, education and programs! IMF Director of Member Events Suzanne Battaglia offers some out-of-the-box ideas for good works that are good fun. Bet you hadn’t thought of having a “Dress Up” day at the office. Now, where’d we put our tiara??? READ MORE
|
|
 |
| Supreme Court Upholds Affordable Care Act |
 |
|
After months of deliberation, the Supreme Court announced this morning that the Affordable Care Act will remain intact and upheld completely. In a 5-4 decision, Chief Justice John Roberts authored an opinion, which was joined by Justices Breyer, Kagan, Sotomayor and Ginsburg, that upheld the constitutionality of the individual mandate because it is a tax. The Court further decided that the Medicaid expansion is constitutional, but that the federal government cannot withhold existing Medicaid funding for states as punishment for states that do not comply with the expansion requirement.
During the two-year debate on healthcare reform, the IMF fought hard on behalf of myeloma patients for specific reforms which were critical to accessing quality care for ALL cancer patients, including:
- The elimination of discrimination based on pre –existing conditions
- The elimination of annual and lifetime insurance caps
- Closing of the Medicare doughnut hole
- Access to affordable health insurance
These key issues were all addressed in the Affordable Care Act. At this time, the IMF will remain focused on the implementation of these reforms to ensure access to care for patients facing a cancer diagnosis.
MORE FROM THE IMF | READ MORE
|
|
|
| Making Sense of ASCO: Our Summaries of Myeloma Abstracts from the ASCO 2012 Annual Meeting |
 |
| Following the International Myeloma Foundation’s 10 STEPS TO BETTER CARE™ framework, we’ve summarized the nearly 66 multiple myeloma presentations from the American Society of Clinical Oncology (ASCO) annual meeting June 2-5 in Chicago. Many focused on therapy options for those with refractory and/or relapsed multiple myeloma, with encouraging data on the use of antibodies and proteasome inhibitors in that setting. READ MORE |
|
|
| An Insider’s Look at Last Week’s Carfilzomib Hearing |
| Dr. Jim Omel played an important role at last week’s FDA hearing on carfilzomib, serving as the myeloma patient representative on the Oncologic Drugs Advisory Committee (ODAC), which voted 11-0 in favor of recommending carfilzomib for approval by the FDA. In his insider’s blog post, Dr. Omel commends the hearing’s patient and IMF representative speakers: “Discussion around the table had a decidedly different tone after the 9 powerful public speakers, and I had great hope for a vote of approval.” READ MORE |
|
 |
|
| Saving a Life, Receiving a Gift: IMF’s Kelly Cox on Being a Bone Marrow Donor |
| IMF staffer Kelly Cox shares his experience as an anonymous bone marrow donor, which has given him first-hand empathy and admiration for myeloma patients who undergo transplantation as part of their cancer therapy. He writes, “Emotionally, spiritually, and intellectually I am absolutely blown away by the experience. And I am still struggling to wrap my mind around the concept of possibly saving a life.” READ MORE |
|
 |
|
| “Survivorship” Tips from the IMF’s Nurse Leadership Board |
| The IMF’s Nurse Leadership Board shared a presentation of its visionary “Survivorship Plans” with oncology nurses from across the country last month at a symposium at the Oncology Nursing Society’s 37th Annual Congress in New Orleans, chaired by Dr. Joseph Tariman, a member of the Nurse Leadership Board. These visionary plans are designed to help patients optimize their health and improve their quality of life. Now we are pleased to share the survivorship plans presented at the congress with the entire myeloma community on the IMF website. READ MORE |
|
 |
|
|
| Join Our Mailing List |
|
| |
|
|
|
|
|
 related videos  related articles |
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
10 PASSI PER CURA MIGLIORE®
10 Steps to Better Care®
10 Steps to Stress Control – From Fear to Hope
10 Steps to Happy Holidays
2011 IMF Holiday Gift Boutique
New Study: The Search for Criteria to Diagnose Active Myeloma at an Early Stage
Comprender El Tratamiento con Dosis Altas con Rescate de Células Madre
Advocacy Update - April 2013
Advocacy Update - March 2013
Advocacy Update - September 2012
Advocacy Update: The Healthcare Landscape in the Aftermath of the 2012 Elections
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference
Breaking News: Pomalyst® (pomalidomide) Approved by the FDA for Relapsed Myeloma
FDA Recognition of Extended Survival with VELCADE® Indicates Important New Progress in Treating the Disease
IMF 6th Annual Comedy Celebration
benefiting the Peter Boyle Research Fund
October 27, 2012
IMF Board Member Edith Mitchell, M.D., FACP, Named 2012 Recipient Of ASCO Humanitarian Award
IMF Nurse Leadership Board (NLB) White Paper on Subcutaneous Velcade® (bortezomib)
IMF Responds to Proposed Changes in CMS PET Scan Policy
It is Officially Myeloma Awareness Month Across the Country!
Live from ASH 2012: Journalists’ Workshop with Leading Myeloma Experts
Live! The Boca Raton Patient & Family Seminar
Living Well with Myeloma Teleconference Series:
How to Prevent Infection in Myeloma Patients
Myelom Merkur - Frühjahr 2012 - #901
MYELOMA AWARENESS MONTH 2012 FACT-A-DAY
Myeloma Canada Announces Recipient of this Year’s Research Grant
Myeloma Minute
April 11, 2013
Myeloma Minute
April 18, 2013
Myeloma Minute
April 26, 2012
Myeloma Minute
February 7, 2013
Myeloma Minute
January 31, 2013
Myeloma Minute
July 26, 2012
Myeloma Minute
March 7, 2013
Myeloma Minute
May 17, 2012
Myeloma Minute
November 8, 2012
Myeloma Minute
October 25, 2012
Myeloma Minute
May 24, 2012
Myeloma Today Spring 2013
New! Free Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
Pomalidomide + carfilzomib trial recruiting patients.
Should Myeloma Patients Get a Flu Shot? If So, Which One?
Special Myeloma Minute on FDA Approved Data for VELCADE®, including long-term survival data
STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED? REFERENCES
STEP 8: KEEPING TRACK OF THE MYELOMA - MONITORING WITHOUT MYSTERY
Stillwater, Minn., Myeloma Support Group Marks "Centennial" Anniversary
Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
The Emerging Role of Kyprolis in the Treatment Paradigm
The IMF Spearheads New Coalition’s First Meeting on State Health Exchanges
The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011
UPCOMING WEBCAST OF THE IMWG CONFERENCE SERIES "MAKING SENSE OF TREATMENT"
Wednesday, June 12, 2013 in Stockhom, Sweden
Клиническое значение электрофореза белковых фракций
back
print